Abstract
In recent years there have been substantial changes in the therapeutic landscape for systemic treatment of advanced prostate cancer (PCa), which resulted in a multitude of novel treatment options for different stages of the disease. In the current narrative review currently available treatment options for metastatic hormone-sensitive PCa as well as nonmetastatic castration-resistant PCa are presented. In addition, current treatment sequence options and targeted treatment in the stage of metastatic castration-resistant PCa are highlighted.
| Dokumententyp: | Zeitschriftenartikel |
|---|---|
| Fakultät: | Medizin |
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
| ISSN: | 0340-2592 |
| Sprache: | Deutsch |
| Dokumenten ID: | 85158 |
| Datum der Veröffentlichung auf Open Access LMU: | 25. Jan. 2022, 09:13 |
| Letzte Änderungen: | 25. Jan. 2022, 09:13 |
- Dokument bearbeiten
